Aster DM Healthcare concludes separation of India, GCC businesses

04 Apr 2024 Evaluate

Aster DM Healthcare has completed the separation of its India and GCC businesses. Under the separation plan, a consortium of investors led by Fajr Capital, a sovereign-backed private equity firm, has acquired a 65% stake in Aster GCC, with the Moopen family retaining a 35% stake alongside management and operational rights. In the Indian operations, the Moopen family continues to hold the 41.88% stake. The transaction has now concluded and pursuant to which Affinity Holdings (a wholly subsidiary of the Company) has received a cash consideration of $907.6 million.

In November 2023, the Company obtained board approvals to separate its GCC and India businesses to establish two distinct regional healthcare champions that will benefit from the strategic and financial flexibility to meet the priorities of patients and focus on the growing demand in their respective markets. The separation plan was also approved by the Company’s shareholders in January 2024. The transaction was subject to customary regulatory approvals, contractual approvals and closing conditions, all of which have been satisfied and concluded.

Aster DM Healthcare operates as a healthcare company in the Middle East, India, and the Far East. It operates hospitals and clinics, pharmacies, diagnostic centers, educational institutions, and healthcare management and healthcare support systems.


Aster DM Healthcare Share Price

343.40 -5.20 (-1.49%)
02-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 343.40
Apollo Hospital Ent. 5953.05
Max Healthcare Inst 815.20
Narayana Hrudayalay 1257.00
Global Health 1429.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.